SGLT1 and SGLT2 inhibitor
This page covers all SGLT1 and SGLT2 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting SGLT1 and SGLT2.
Targets
Phase 3 pipeline (1)
- RT001 · Biojiva LLC · Diabetes
RT001 is a small molecule drug that targets the SGLT1 and SGLT2 transporters.
Patent intelligence
- sglt1 and sglt2 inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates